HCAT Stock Cash Flow Statements

Health Catalyst Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

Health Catalyst Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30

cash flows from operating activities
net income	-20,673,000	-14,726,000	-13,516,000	-20,587,000	-30,312,000	-22,032,000	-32,613,000	-33,190,000	-35,782,000	-45,735,000	-33,428,000	-22,458,000	-48,992,000	-40,014,000	-35,834,000	-28,370,000	-43,018,000	-27,326,000	-27,183,000	-17,490,000	-14,266,000	-21,416,000
adjustments to reconcile net income to net cash from operating activities:
stock-based compensation expense	10,812,000	9,512,000	8,966,000	10,838,000	13,011,000	14,232,000	14,629,000	13,884,000	18,748,000	17,304,000	17,932,000	18,120,000	16,421,000	17,487,000	17,727,000	13,510,000	10,674,000	9,496,000	9,046,000	8,741,000	4,816,000	9,974,000
depreciation and amortization	10,266,000	9,983,000	10,657,000	10,525,000	10,304,000	10,190,000	10,735,000	10,994,000	11,664,000	12,372,000	12,612,000	11,649,000	10,924,000	10,651,000	8,139,000	7,814,000	7,773,000	4,981,000	3,094,000	2,877,000	2,368,000	2,316,000
investment discount and premium accretion	-858,000	-751,000	-1,183,000	-1,965,000
impairment of long-lived assets	0	0	0	2,200,000	1,400,000	0			98,000
non-cash operating lease expense	704,000	547,000	653,000	781,000	718,000	735,000	773,000	764,000	773,000	798,000	841,000	819,000	420,000	1,239,000	961,000	965,000	1,438,000	1,296,000
benefit from expected credit losses	-2,231,000	-5,000	1,033,000	2,405,000	195,000	99,000	13,000	1,514,000	-9,000	300,000	200,000	200,000	-199,000	300,000	98,000	300,000	41,000	-14,000
amortization of debt discount, issuance costs, and deferred financing costs	1,178,000
deferred tax provision	594,000	-533,000	2,000	14,000	2,000	2,000	2,000	2,000			-931,000	-3,598,000			2,000	2,000
change in fair value of contingent consideration liabilities	0								0	2,635,000	1,121,000	-8,424,000	6,381,000	4,591,000	6,908,000	2,156,000	15,092,000
payment of acquisition-related contingent consideration													2,681,000	-741,000
other	54,000	75,000	8,000	4,000	-34,000	70,000	12,000	19,000	-74,000	7,000	-29,000	-49,000	-36,000	8,000	9,000	-34,000	31,000	14,000	73,000	-2,000
change in operating assets and liabilities:
accounts receivable	-2,023,000	4,257,000	-1,964,000	4,011,000	-13,922,000	6,195,000	9,469,000	-15,405,000	1,588,000	-2,094,000	-4,725,000	6,019,000	-919,000	94,000	-1,163,000	2,090,000	-11,998,000	2,729,000	105,000	-7,284,000	3,450,000	3,453,000
prepaid expenses and other assets	567,000	-2,539,000	1,622,000	300,000	-221,000	64,000	741,000	-420,000	-2,498,000	436,000	1,147,000	437,000	-2,311,000	-583,000	625,000	-2,173,000	-730,000	-444,000	-249,000	-2,244,000	-275,000	-978,000
accounts payable, accrued liabilities, and other liabilities	771,000	7,190,000	3,115,000	-5,495,000	3,021,000	3,142,000	-9,004,000	7,709,000	-5,575,000	5,759,000	-74,000	-4,812,000	1,921,000	5,720,000	2,913,000	-5,352,000	1,676,000	7,623,000	3,227,000	-4,283,000	-1,747,000	3,305,000
deferred revenue	-1,753,000	-5,760,000	-7,300,000	7,801,000	201,000	-6,242,000	-6,473,000	11,027,000	-1,632,000	-4,739,000	-3,732,000	4,106,000	1,097,000	-925,000	3,720,000	3,745,000	12,297,000	-5,313,000	539,000	3,936,000	-7,524,000	-2,075,000
operating lease liabilities	-935,000	-719,000	-861,000	-945,000	-879,000	-901,000	-896,000	-876,000	-874,000	-872,000	-890,000	-882,000	-481,000	-1,295,000	-1,024,000	-1,083,000	-713,000	-918,000	-999,000	-784,000	-765,000	-742,000
net cash from operating activities	-3,527,000	6,208,000	1,612,000	10,266,000	-19,041,000	3,115,000	-11,574,000	-5,580,000	-14,821,000	-12,031,000			-9,775,000	-5,360,000	-4,845,000	-3,143,000	-4,141,000	-4,487,000	-751,000	-16,769,000	-13,061,000	-5,482,000
capex	-4,829,000	-4,276,000	-4,047,000	-2,738,000	-2,881,000	-3,323,000	-3,525,000	-3,289,000	-3,378,000	-4,521,000			-623,000	-4,032,000	-3,281,000	-6,769,000	-5,704,000	153,000	-431,000	-429,000	-687,000	-450,000
free cash flows	-8,356,000	1,932,000	-2,435,000	7,528,000	-21,922,000	-208,000	-15,099,000	-8,869,000	-18,199,000	-16,552,000			-10,398,000	-9,392,000	-8,126,000	-9,912,000	-9,845,000	-4,334,000	-1,182,000	-17,198,000	-13,748,000	-5,932,000
cash flows from investing activities
proceeds from the sale and maturity of short-term investments	35,579,000	48,288,000	21,200,000	137,000,000	80,700,000	67,501,000	81,500,000	107,100,000	45,000,000	85,000,000	104,211,000	80,960,000	0	12,600,000	121,053,000	53,240,000	10,602,000	84,317,000	57,497,000	66,653,000	13,400,000	24,980,000
purchases of short-term investments
capitalization of internal-use software	-4,416,000	-3,571,000	-3,757,000	-2,530,000	-2,626,000	-2,942,000	-3,525,000	-2,864,000	-2,963,000	-2,998,000	-3,765,000	-3,261,000		-1,729,000	-1,025,000	-887,000
acquisition of businesses, net of cash acquired	-25,388,000	-36,230,000															814,000
purchases of property and equipment	-413,000	-705,000	-290,000	-208,000	-255,000	-149,000			-415,000	-1,194,000			-623,000	-1,689,000	-2,256,000	-5,882,000	-5,704,000	-1,004,000	-561,000	-506,000	-741,000	-595,000
purchases of intangible assets
proceeds from the sale of property and equipment	3,000	3,000	4,000	3,000	10,000	10,000	5,000	6,000	9,000	10,000	6,000	4,000	3,000	7,000	6,000	6,000	4,000	0	4,000	6,000	22,000	2,000
net cash from investing activities	-112,749,000	7,646,000	-1,783,000	83,984,000	29,917,000	-24,858,000	-7,415,000	22,649,000	6,256,000	-33,182,000	-13,751,000	1,656,000	-76,683,000	-172,794,000	72,423,000	37,376,000	-21,905,000	-3,976,000	-106,830,000	50,146,000	-22,070,000	-157,318,000
cash flows from financing activities
proceeds from issuance of long-term debt, net of issuance costs	36,805,000
payment of deferred financing costs	848,000
repayment of debt
proceeds from employee stock purchase plan	350,000	630,000	588,000	843,000	382,000	1,000,000	1,032,000	1,174,000	595,000	1,027,000	22,000	1,509,000	869,000	1,356,000	1,270,000	1,349,000	745,000	1,120,000	1,119,000	1,289,000	1,762,000
proceeds from exercise of stock options	0	39,000	110,000	20,000	13,000	40,000	170,000	727,000	42,000	239,000	1,879,000	1,809,000	3,047,000	3,227,000	7,588,000	6,488,000	6,871,000	14,383,000	5,964,000	9,046,000	479,000	552,000
repurchase of common stock					0	0	0	-1,808,000	0
payments of acquisition-related consideration									0	-412,000	0	-930,000	0	-930,000	-3,969,000	-1,391,000	-876,000	0	0	-748,000	-940,000	0
net cash from financing activities	37,690,000	112,495,000	698,000	863,000	395,000	1,040,000	1,202,000	93,000	637,000	-7,539,000	1,901,000	2,388,000	3,916,000	248,833,000	4,889,000	6,446,000	6,740,000	15,503,000	150,779,000	9,587,000	1,098,000	194,040,000
effect of exchange rate changes on cash and cash equivalents	-96,000	83,000	-2,000	-19,000	34,000	-15,000	-3,000	5,000	16,000	-7,000	-19,000	-1,000	4,000	-9,000	1,000	-6,000
net increase in cash and cash equivalents	-78,682,000	126,432,000	525,000	95,094,000				17,167,000	-7,912,000	-52,759,000	-21,445,000	5,201,000	-82,538,000	70,670,000	72,468,000	40,673,000	-19,285,000	7,054,000	43,220,000	42,933,000	-34,027,000	31,240,000
cash and cash equivalents at beginning of period	0			106,276,000	0	0				0				0				0	0	18,032,000	0	0
cash and cash equivalents at end of period	-78,682,000			201,370,000	11,305,000	-20,718,000				-52,759,000				70,670,000				7,054,000	43,220,000	60,965,000	-34,027,000	31,240,000
purchase of short-term investments		0	0	-50,197,000	-36,388,000	-89,260,000	-84,118,000	-81,070,000	-34,432,000	-113,981,000	-103,829,000	-56,719,000	-72,956,000	-134,721,000	-45,065,000	-8,621,000	-26,180,000	0			-34,563,000	-180,935,000
purchase of intangible assets		-139,000	-281,000	-84,000	-132,000	-18,000	-870,000	-98,000	-943,000	-19,000	-835,000	-463,000	-104,000	-499,000	-290,000	-480,000	1,000	-67,000	-424,000	-758,000	-188,000	-770,000
repayment of seller-financed debt
supplemental disclosures of non-cash investing and financing information
common stock issued in connection with acquisitions										0
stock-based compensation capitalized as internal-use software						254,000				190,000				158,000
purchase of property and equipment included in accounts payable and accrued liabilities						-25,000				-329,000				-614,000				1,157,000	130,000	77,000	54,000	145,000
capitalized internal-use software included in accounts payable and accrued liabilities						-207,000
operating lease right-of-use assets obtained in exchange for operating lease obligations						0				0								11,419,000			0	0
purchase of intangible assets included in accounts payable and accrued liabilities						0				526,000				-575,000						132,000	322,000	0
amortization of debt discount and issuance costs			380,000	379,000	379,000	378,000	377,000	377,000	376,000	375,000	375,000	374,000	3,105,000	3,026,000	2,947,000	2,870,000	2,794,000	2,720,000	2,255,000	285,000	284,000	281,000
investment (discount accretion) and premium amortization
proceeds from public offerings, net of discounts, commissions, and offering costs
supplemental disclosures of cash flow information
cash paid for interest
cash paid for income taxes
investment discount and premium amortization						-2,817,000						398,000	524,000	109,000	152,000	417,000	495,000	587,000	273,000	-6,000	-172,000	-169,000
contingent consideration liabilities										-2,493,000	0	-741,000
net decrease in cash and cash equivalents						-20,718,000
common stock issued for settlement of contingent consideration										7,746,000				4,202,000
investment (discount) premium amortization								-1,979,000
acquisition of business, net of cash acquired										0	-9,337,000	-18,509,000							0	-15,249,000
purchase of property and equipment								-425,000				-356,000
loss on extinguishment of debt																	0	0			0	0
deferred tax benefit									4,000									0	0	-1,280,000
proceeds from convertible senior notes, net of issuance costs																	0	0
purchase of capped calls concurrent with issuance of convertible senior notes																	0
repayment of credit facilities																	0	0
amortization of investment discount and premium										-1,011,000
proceeds from public offering, net of discounts, commissions, and offering costs
net cash from (used) in operating activities												1,158,000
impairment of lease-related assets													0
capitalization of internal use software
proceeds from credit facilities, net of debt issuance costs																					0	0
proceeds from the issuance of redeemable convertible preferred stock
payments of deferred offering costs																					-203,000	-2,377,000
purchase of capped calls related to issuance of convertible senior notes
deferred costs																			38,000	444,000	41,000	-133,000
proceeds from initial public offering, net of underwriters' discounts and commissions
proceeds from the issuance of redeemable convertible preferred stock, net of issuance costs																					0	0
proceeds from initial public offering, net of underwriters’ discounts and commissions
effect of exchange rate changes																		14,000	22,000	-31,000
redeemable convertible preferred stock accretion																					0	18,170,000
deferred offering costs included in accounts payable and accrued liabilities																				427,000		-965,000
change in fair value of contingent consideration liability																			-1,209,000	-359,000
gain on sale of property and equipment																				-2,000	-3,000	-2,000
operating lease right-of-use assets																				682,000	707,000	704,000
payment of svb line of credit and mezzanine loan																					0	0
supplemental disclosures of cash flow information related to leases
cash paid for operating lease liabilities in operating cash flows																				843,000	822,000	821,000
change in fair value of warrant liability
series e redeemable convertible preferred stock allocated to business combination

We provide you with 20 years of cash flow statements for Health Catalyst stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Health Catalyst stock. Explore the full financial landscape of Health Catalyst stock with our expertly curated income statements.

The information provided in this report about Health Catalyst stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.